Business context and reporting period
Entity discrepancy: The supplied filing is for CopyTele, Inc. and subsidiaries, not Anixa Biosciences, Inc. It is a Form 10-Q for the three months ended January 31, 2012 (the first quarter of CopyTele’s fiscal 2012), filed March 16, 2012. The financial statements are unaudited.
CopyTele developed and marketed display technologies and encryption products. Display-technology licensing drove nearly all reported revenue this quarter.
Key financial metrics
| Metric | Three months ended Jan. 31, 2012 | Prior-year comparable period |
|---|---|---|
| Net revenue | $449,195 | $16,958 |
| Operating loss | $(887,256) | $(1,526,138) |
| Net loss | $(886,085) | $(1,526,109) |
| Net loss per share, basic and diluted | $(0.00) | $(0.01) |
| Net cash used in operating activities | $(657,257) | $(609,649) |
Revenue included $446,670 of AU Optronics Corp. (AUO) display-license revenue and $2,525 from encryption products. Research and development was $649,679; selling, general and administrative expense was $686,035. No income tax provision was recorded.
At January 31, 2012, cash and cash equivalents were $463,037 and short-term investments were $2,049,579. Working capital was approximately $554,000. Total assets were $8.03 million; total current liabilities were $2.06 million. The company reported a $5.0 million related-party loan payable, due in December 2014, and a matching $5.0 million loan receivable classified as contra-equity. Contractual obligations totaled $6.04 million, including the secured loan and operating leases.
Cash, cash equivalents, and short-term investments together were approximately $2.51 million, down about $510,000 from October 31, 2011. The separate Videocon investment was carried at $5.28 million; its quarter-period unrealized loss was $104,709.
Material changes versus the prior comparable period
- Revenue increased about $432,000, primarily because the company recognized AUO license revenue; encryption-product revenue fell by about $14,000.
- Net loss narrowed by about $640,000. Research and development and selling, general and administrative expenses fell by approximately $127,000 and $75,000, respectively, largely reflecting lower stock-option and employee compensation costs.
- Operating cash use increased by about $48,000. Stock-option exercise proceeds were $147,250, compared with $477,850 in the prior-year quarter.
- Common shares outstanding rose from 176.1 million at October 31, 2011 to 180.5 million at January 31, 2012, largely through shares issued for employee and consultant services and option exercises.
Outlook, risks, contingencies, and unusual items
- Management said available cash and investments, expected product sales and display-technology revenue, and other potential cash sources should fund operations for at least 12 months from period-end. It cautioned that actual cash needs and receipts could differ and that additional financing might not be available on favorable terms; equity or convertible-debt financing could dilute shareholders. The company had no additional financing arrangements.
- Under the AUO agreements, up to $10 million in license fees are payable: $3 million was paid in June 2011, netting $2.4 million after withholding tax; a further $7 million is conditional on completion of specified conditions. The company recognized $446,670 of the initial fee this quarter and reported approximately $1.681 million of deferred AUO license revenue. Royalties depend on future production, and none had been recognized.
- Videocon’s license agreement contemplated $11 million in fees, but payments had been deferred. CopyTele had received $3.2 million in aggregate and received none in this quarter; it was discussing further payments but could not estimate timing. No royalties had been earned under that agreement.
- Revenue was highly concentrated: one display-technology customer represented 100% of segment revenue and 99% of total revenue in the quarter. Encryption sales remained limited.
- Management warned that insufficient revenues or financing, inadequate production capability, competing or obsolete products, or employees and consultants no longer accepting stock compensation could require the company to curtail or cease operations. Certain employees who had received stock compensation were paid in cash after January 2012.
- The Videocon global depository receipts were exposed to market-price and foreign-exchange risk; the filing estimated an approximately $528,000 loss from a hypothetical 10% adverse movement in the relevant share prices and exchange rates. The filing reported no material pending litigation and no material changes to previously disclosed risk factors.
- Management concluded disclosure controls were effective and reported no material change in internal control over financial reporting during the quarter.
Important facts for investors to verify
- Confirm the issuer: this document identifies CopyTele, Inc., not Anixa Biosciences, Inc.
- Check AUO’s progress toward the conditions for the remaining $7 million in license fees and the timing and collectability of any royalties.
- Monitor Videocon payment discussions, given the deferred fees, uncertain timing, and lack of royalties to date.
- Assess cash runway against operating cash use, reduced working capital, the shift of some compensation to cash, and the $5 million related-party obligation due in December 2014.
- Track dependence on a single display-technology customer, ongoing operating losses, share issuance and potential dilution, and the market and currency exposure of the Videocon investment.